Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment
Jordi Bruix, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, G. Bodoky, Marc Pracht, Yokosuka, Olivier Rosmorduc, В. В. Бредер, René Gerolami, Gianluca Masi, P.J. Ross, S. Qin, Tae-Jin Song, J.-P. Bronowicki, Isabelle Ollivier‐Hourmand, Masatoshi Kudo, Annette Baumhauer, Marine Leberre, Gudrun Meinhardt, Guohong Han
Cited by 12
Abstract
Related Papers
No related papers found
Powered by citation graph analysis